Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy
Clinical trial NCT00629187 · TERMINATED
Trial details
- NCT number
- NCT00629187
- Sponsor
- Tufts Medical Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2012-04-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.